Top Story

Selinexor plus dexamethasone active in refractory multiple myeloma

April 19, 2018
FDA News

FDA grants fast track designation to selinexor for penta-refractory myeloma

April 11, 2018
The FDA granted fast track designation to selinexor for treatment of certain patients with penta-refractory multiple myeloma, according to the agent’s…

ASH president: Society ‘has tremendous capacity’ to advance, improve care around the world

April 2, 2018
Alexis A. Thompson, MD, MPH, took over as ASH president in January. Thompson — head of the hematology section in the division of hematology, oncology and…

Myeloma Action Month: 7 recent updates on treatment

March 20, 2018
In 2009, the International Myeloma Foundation declared March Myeloma Awareness Month to bring attention to the second most common blood cancer. However, since that time…
More Headlines »

Virtual NSCLC: Updates in Combining Immunotherapy with Other Treatment Modalities

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »
Meeting News Coverage

VIDEO: Physicians must wait for STAMINA data to ‘really play out’ for posttransplant myeloma treatment

December 29, 2016
More »
Resource Centers
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting


EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of…
More »